Christopher Gibson (RXRX) logs conversions, sales and RSU vesting in Form 4
Rhea-AI Filing Summary
Recursion Pharmaceuticals director Christopher Gibson reported several stock transactions in early February 2026. On February 4, he converted 40,000 shares of Class B Common Stock into Class A at $0 per share, then sold 40,000 Class A shares at $4.12 under a pre-arranged Rule 10b5-1 trading plan.
On February 6, Gibson received 30,346 Class A shares from restricted stock units that vested immediately at $0, and 10,364 shares were withheld at $3.56 to cover taxes. After these transactions, he directly held 933,821 Class A shares, alongside sizable option and convertible Class B positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 40,000 shares ($165K approx. pre-tax spread)
Exercise and Sale
14 txns
Insider
Gibson Christopher
Role
Director
Sold
40,000 shs ($165K)
Approx. gross sale proceeds
$165K
Approx. exercise cost
$0.00
Approx. pre-tax spread
$165K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 30,346 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 10,364 | $3.56 | $37K |
| Conversion | Class B Common Stock | 40,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 40,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 40,000 | $4.12 | $165K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 4,583,334 shares (Direct);
Class A Common Stock — 933,821 shares (Direct);
Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC);
Class B Common Stock — 0 shares (Indirect, by LAHWRAN-4 LLC);
Class B Common Stock — 0 shares (Indirect, by Gibson Family Trust);
Stock Option (Right to Buy) — 0 shares (Direct)
Footnotes (12)
- F1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F2. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- F3. This RSU vested immediately upon the grant date.
- F4. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- F5. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- F6. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- F7. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- F8. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F9. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F10. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F11. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- F12. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Christopher Gibson report for RXRX in February 2026?
Christopher Gibson reported converting 40,000 Class B shares to Class A, selling 40,000 Class A shares at $4.12, receiving 30,346 Class A shares from vested RSUs, and having 10,364 shares withheld for taxes, all in early February 2026.
Were Christopher Gibson’s February 2026 RXRX stock sales pre-planned?
Yes. The Form 4 states that the February 4, 2026 sale of 40,000 Class A shares at $4.12 occurred under a Rule 10b5-1 trading plan that Gibson adopted on May 12, 2025, indicating the sale followed a pre-established trading program.